A neurologist's personal battle against Alzheimer's disease
Today I was interviewed for nearly 90 minutes by a reporter from the Flemish newspaper De Morgen for an upcoming book review of the Dutch language edition of A Tattoo on my Brain that was released last week....
Yesterday evening as sundown approached, I looked out a window on the west side of our house and saw a startling headless reflection looking back enquiringly at me. The optics were easily explained: I...
My second book, Dispatches from the Land of Alzheimer’s, was released today in the US by Cambridge University Press. It is a collection of essays about Alzheimer’s disease that I have written over the last few...
On April 2, I will be participating in a panel discussion following a screening of the documentary film Keys Bags Names Words. This event will be held at 7 – 9 pm at the Smith Memorial...
Dr. Steven Greenberg is most likely the most knowledgeable expert in the world concerning cerebral amyloid angiopathy (CAA) and the vascular pathology associated with Alzheimer’s disease. Earlier this week, I had the honor of...
Yesterday the Daily Mail published an article based on my new book, Dispatches From the Land of Alzheimer’s. I think the Daily Mail editors did a really good job of organizing excerpts from the book...
On January 31, Biogen put out a press release indicating that it “plans to reprioritize its resources in Alzheimer’s disease” by halting development and marketing of the anti-amyloid monoclonal antibody aducanumab (Aduhelm). Patients currently...
As can be seen in this display window at the Cambridge University Press bookshop, my new book is now available in the UK and Europe. The book release date in the US is currently...
About a month ago, I received an invitation to give a 10-minute talk on January 17 to The National Academies Committee on Research Priorities for Preventing and Treating Alzheimer’s Disease and Related Dementias. This two-day...
Last week in the New England Journal of Medicine, the results of an interesting proof-of-concept study using focused ultrasound to enhance the ability of the anti-amyloid monoclonal antibody aducanumab to cross the blood blood-brain barrier...
Recent Comments